Canada· CA-DIN-02400081
CLOXACILLIN FOR INJECTION
A cloxacillin product containing cloxacillin (cloxacillin sodium), registered in Canada by STERIMAX INC. The same ATC class is registered in 8 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Cloxacillin is registered in 8 of 19 countries.
Countries holding a registration under ATC J01CF02 (cloxacillin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Cloxacillin · ATC J01CF02
8 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Norwayprice
- Polandprice
- Sweden
Price per daily dose
What a daily dose of cloxacillin costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cloxacillin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- FI Finland$5.89
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CLOXACILLIN (CLOXACILLIN SODIUM)
- Manufacturer
- STERIMAX INC
- Country
- Canada (CA)
- ATC code
- J01CF02
- ATC class
- Cloxacillin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for cloxacillin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cloxacillin · interactions on record
22 records
- 3 severe
- 17 moderate
- 2 minor
Most severe, free to view
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- MethotrexatM01CX01severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cloxacillin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCloxacillin MacureMacure Healthcare Limited
- FranceCLOXACILLINE ARROW 500 mg, géluleARROW GENERIQUES
- SwedenCloxacillin Macure 1 g Pulver till injektions-/infusionsvätska, lösningMacure Healthcare Limited
- SpainANACLOSIL 1000 mg polvo para solución inyectable y para perfusiónLaboratorio Reig Jofre, S.A.
- PolandCloxacillin EugiaEugia Pharma (Malta) Ltd.
- NorwayCloxacillin NavamedicNavamedic ASA
- IcelandCloxacillin NavamedicNavamedic ASA
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Cyprus · Cloxacillin Remedica, Monoclox
- Denmark · Cloxacillin Macure, Cloxacillin Navamedic
- Estonia · Cloxacillin Auxilia
- Spain · Anaclosil, Cloxacilina Normon
- Finland · Cloxacillin Macure, Cloxacillin Navamedic
- France · Cloxacilline Arrow, Cloxacilline Biogaran
- Greece · Staphyclox
- Croatia · Monoclox
- Iceland · Cloxacillin Navamedic, Cloxacillin Xgx Pharma
- Norway · Cloxacillin Macure, Cloxacillin Navamedic
- Poland · Cloxacillin Eugia, Cloxacillin Polpharma
- Portugal · Cloxacilina Generis
- Sweden · Cloxacillin Macure, Cloxacillin Navamedic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f84a80e-b51b-42cd-9a49-e081d0f8820d GET /v1/drugs/8f84a80e-b51b-42cd-9a49-e081d0f8820d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02400081",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J01CF02",
"schedule": [
"Prescription"
],
"drug_code": "88492",
"strengths": [
"10 G"
],
"ahfs_class": null,
"substances": [
"CLOXACILLIN (CLOXACILLIN SODIUM)"
],
"product_categorization": null
}See everything about cloxacillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.